DAIKEN MEDICAL CO.,LTD. [7775.T]
TOKYO, May 15 (Pulse News Wire) – Daiken Medical Co., Ltd. (7775.T) reported non-consolidated results for fiscal year 2026 ending March.
Revenue was ¥10.3 billion (+3.4% YoY). operating profit was ¥1,277 million (-15.5%). net profit attributable to shareholders was ¥922 million (-15.9%).
Total assets stood at ¥11.4 billion with an equity ratio of 68.2%. The company declared an annual dividend of ¥11 per share. The full-year forecast for the current fiscal year is revenue of ¥10.5 billion (+2.0%).
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥10,290M | +3.4% |
| Operating profit | ¥1,277M | -15.5% |
| Net profit | ¥922M | -15.9% |
Next period forecast
Revenue
¥10,500M
+2.0%Op. profit
¥840M
-34.3%Net profit
¥590M
-36.1%Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.